CAS 7772-94-3
:2-(Acetilamino)-2-desoxi-β-D-manopiranose
- 2-(Acetylamino)-2-Deoxyhexopyranose Hydrate
- 2-(Acetylamino)-2-deoxy-β-<span class="text-smallcaps">D</span>-mannopyranose
- 2-(acetylamino)-2-deoxy-alpha-D-gulopyranose
- Mannopyranose, 2-acetamido-2-deoxy-, β-<span class="text-smallcaps">D</span>-
- N-Acetyl-D-mannosamine monohydrate
- β-<span class="text-smallcaps">D</span>-Mannopyranose, 2-(acetylamino)-2-deoxy-
- 2-(Acetylamino)-2-deoxy-β-D-mannopyranose
- β-D-Mannopyranose, 2-(acetylamino)-2-deoxy-
- Mannopyranose, 2-acetamido-2-deoxy-, β-D-
N-Acetyl-D-mannosamine
CAS:Fórmula:C8H15NO6·xH2OPureza:≥ 98.0%Cor e Forma:White to off-white powderPeso molecular:221.21 (anhydrous)2-(Acetamido)-2-deoxy-β-D-mannopyranose
CAS:2-(Acetamido)-2-deoxy-β-D-mannopyranosePureza:97% (Monohydrate)Peso molecular:221.21g/molN-Acetyl-D-mannosamine
CAS:N-Acetyl-D-mannosamineCor e Forma:White To Off White PowderPeso molecular:239.22g/molCyclic N-Acetyl-D-mannosamine
CAS:Cyclic N-Acetyl-D-mannosamine is used for sialic acid synthesis and as a precursor for biologically active compounds.Fórmula:C8H15NO6Pureza:99.18% - 99.72%Cor e Forma:White Crystal PowderPeso molecular:221.21N-Acetyl-D-mannosamine
CAS:N-Acetyl D-mannosamine (ManNAc) is an aldohexose (2-acetamido-2-deoxymannose) in which the axial hydroxyl group at position 2 is replaced by a N-acetyl group (Collins, 2006). It has been reported that N-acetyl D-mannosamine supplementation, may provide novel means to break the link between obesity and hypertension (Peng, 2019). N-Acetyl-D-mannosamine and N-acetyl-D-glucosamine are the essential precursors of sialic acid, the specific monomer of polysialic acid, a bacterial pathogenic determinant, for example, Escherichia coli K1 uses both amino sugars as carbon sources. Glycoproteins normally have some level of glycan sialylation, but incomplete sialylation can reduce their therapeutic effect when produced recombinantly. To improve performance, cell lines and culture media can be adjusted. The GNE enzyme controls the efficiency of sialylation in human cell lines, making it crucial for producing effective recombinant glycoprotein drugs. Adding ManNAc and other supplements to culture media improves sialylation, which boosts drug yield, increases stability and half-life, and lowers immune reactions by reducing antibody formation.It has also been reported that ManNAc can be used as a treatment for hereditary inclusion body myopathy, an adult-onset, progressive neuromuscular disorder and also for renal disorders involving proteinuria and hematuria due to podocytopathy and/or segmental splitting of the glomerular basement membrane (Galeano, 2007).Fórmula:C8H15NO6Pureza:Min. 97.5 Area-%Peso molecular:221.21 g/molN-Acetyl-D-mannosamine - low endotoxin grade
CAS:Please enquire for more information about N-Acetyl-D-mannosamine - low endotoxin grade including the price, delivery time and more detailed product information at the technical inquiry form on this pageFórmula:C8H15NO6Peso molecular:221.21 g/molN-Acetyl-D-mannosamine
CAS:N-Acetyl D-mannosamine (ManNAc) is an aldohexose (2-acetamido-2-deoxymannose) in which the axial hydroxyl group at position 2 is replaced by a N-acetyl group (Collins, 2006). It has been reported that N-acetyl D-mannosamine supplementation, may provide novel means to break the link between obesity and hypertension (Peng, 2019). N-Acetyl-D-mannosamine and N-acetyl-D-glucosamine are the essential precursors of sialic acid, the specific monomer of polysialic acid, a bacterial pathogenic determinant, for example, Escherichia coli K1 uses both amino sugars as carbon sources. It has been reported that ManNAc can be used as a treatment for hereditary inclusion body myopathy, an adult-onset, progressive neuromuscular disorder and also for renal disorders involving proteinuria and hematuria due to podocytopathy and/or segmental splitting of the glomerular basement membrane (Galeano, 2007).
Fórmula:C8H15NO6Pureza:Min. 98 Area-%Cor e Forma:White PowderPeso molecular:221.21 g/molRef: 3D-MA05269
Produto descontinuado





